WINDSOR, ONTARIO, CANADA, July 9, 2021 /EINPresswire.com/ – Emergence Global Enterprises Inc. (“Emergence Global” or the “Company”) (CSE: EMRG) (OTCQB: ELOAF), an acquirer, creator and builder of consumer foods, renowned natural health products and brands, is pleased to announce that it has completed the payment of shares for services rendered to the Company by professional and advisory staff from November 2019 to April 2021 During this period, the Company relied on consultants and advisers to provide services as the Company had no employees at that time. A total of 8.05 million shares are distributed under this issuance to satisfy the advisory agreements for the period from November 2019 to April 2021.
The company announces that Bahige (Bill) Chaaban is stepping down as chairman to focus on leading our M&A plan. Bill will continue to serve as a director of the company. Joseph Byrne will assume the responsibility as President and CEO effective immediately.
On April 12, 2021, the Company announced the recruitment and hiring of its management team and finalized the structure of its board of directors. The current members of the board are Joseph Byrne, president; Brian Payne, secretary; Diego Rodriguez, treasurer; and directors Bahige Chaaban, Cameron Canzellerini and Christian Gallant.
Additional information on the Company is available on SEDAR under the issuer profile of “Emergence Global Enterprises Inc. or on OTC MARKETS.
About the company
Emergence Global Enterprises Inc. (“Emergence”) is a reputable acquirer, designer and manufacturer of consumer foods, natural health products and brands. Emergence has grown into a North American developer and distributor of branded natural health foods, supplements and specialty sports nutrition supplements. The Company is currently considering several development projects.
For more information on the Company, please contact: Joseph Byrne, Chief Executive Officer and Director by phone: 519-257-0460 or by email at: [email protected]
Caution regarding forward-looking information
This press release includes certain “forward-looking statements” under applicable Canadian securities laws. Forward-looking statements include, without limitation, statements regarding: the closing and the terms and conditions of the proposed transaction; the affairs and operations of the Company after the closing of the proposed transaction. Forward-looking statements are necessarily based on a number of estimates and assumptions which, although believed to be reasonable, are subject to known and unknown risks, uncertainties and other factors that may cause actual results and future events differ materially from those expressed or implied. by such forward-looking statements. These factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Therefore, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the proposed transaction will be completed or that the anticipated financial, economic or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its market regulator (as that term is defined in the policies of the Canadian Securities Exchange) or OTC Markets accepts responsibility for the adequacy or accuracy of this release. Press.
Brian S. Payne
Emergence Global Enterprises Inc.
write us here
Visit us on social networks: